Skip to main content
TipRanks
Go Ultimate75% OFF

Jonathan Lord Insider Profile

4 Followers

Jonathan Lord, Director at Dexcom, holds 59.92K shares in BIOLASE (Ticker: BIOLQ), holds 131.58K shares in Dexcom (Ticker: DXCM), holds 100.00 shares in Stericycle (Ticker: SRCL). Most recently, Jonathan Lord Sold ― shares of BIOLASE on Dec 08, 2022 for an estimated value of $2.65K.

Jonathan Lord's Trading History

BIOLQ
BIOLASE
Dec 08, 2022―Informative Sell2.65K―
DXCM
Dexcom
Sep 06, 2016DirectorInformative Sell915.00K$10.96M
SRCL
Stericycle
Jul 02, 2013―Informative Sell664.40K$6.20K
HUM
Humana
Feb 05, 2009Sr VP & Chief Innovation Off.Uninformative Sell326.71K$24.98M
NURO
Neurometrix
―――$0.00
MAKO
Mako Surgical
――――

You May Also Like

Jonathan Lord insider profile FAQ

What is the percentage of profitable transactions made by Jonathan Lord?
The percentage of profitable transactions made by Jonathan Lord is 38%.
What is the average return per transaction made by Jonathan Lord?
The average return per transaction made by Jonathan Lord is -12.80%.
What stocks does Jonathan Lord hold?
Jonathan Lord holds: DXCM, BIOLQ, HUM, SRCL, MAKO, NURO stocks.
What was Jonathan Lord’s latest transaction?
Jonathan Lord’s latest transaction was an Informative Sell of $2.65K.
What was Jonathan Lord's most profitable transaction?
Jonathan Lord’s most profitable transaction was an Informative Buy of BIOLQ stock on November 11, 2015. The return on the trade was 116.20%.
What is Jonathan Lord's role in Dexcom?
Jonathan Lord's role in Dexcom is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.